Research partially funded by the JKTG Foundation recently appeared recently in the Bulletin of Mathematical Biology.
The research, Intermittent Hormone Therapy Models Analysis and Bayesian Model Comparison for Prostate Cancer, includes work by Heiko Enderling, Ph.D., a researcher with whom JKTG has worked on several projects.
As described in the published abstract, first-line therapy for prostate cancer includes androgen deprivation therapy (ADT), depriving both the normal and malignant prostate cells of androgens required for proliferation and survival.
In recent years, intermittent ADT has been proposed as an alternative to continuous ADT. Several mathematical models with different biological resistance mechanisms have been considered to simulate intermittent ADT response dynamics.
The research compares 13 intermittent dynamical models and assess their ability to describe prostate-specific antigen (PSA) dynamics.
Featured news
Ted’s Take: Errors in formulas and what it means for AI
Spinach is the best source of iron. I’ve understood this for decades now. As I ate more and more healthy foods, I’d choose spinach salads because of the “great” nutritional value, particularly iron.
Ted’s Take: An ounce of prevention
They stay an ounce of the prevention is worth a pound of cure. Isn’t it the truth.
How physicians are paid
Despite a growing need for general practitioners, the Medicare system is not helping with this shortage given the maldistribution of reimbursement between general medical providers and surgeons and other specialists.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133